
    
      In this clinical trial 50 patients with insulin dependent type 2 diabetes will be randomised
      in two study arms: monitoring of blood glucose and blood pressure using a telemedical device
      or in an arm with treatment as usual. Patients will the following measurement devices: blood
      glucose, blood pressure. Both devices can communicate with a mobile phone, which will also be
      provided to the patients. The mobile phone will transfer the data to a central, safe server.
      Patients will receive automated reminder/feedback. Caregivers can evaluate the transferred
      data whenever necessary via a web-based access. Data will be presented in tables as well as
      trend figures.
    
  